CTOs on the Move


 
Agenus is an immunology company developing a series of Checkpoint Modulators for the treatment of patients with cancer, infectious diseases, and other immune disorders, heat shock protein (HSP)-based vaccines, and immune adjuvants. These programs are supported by three separate technology platforms. Agenus’ internal and partnered checkpoint modulator programs target GITR, OX40, CTLA-4, LAG-3, TIM-3, PD-1 and other undisclosed programs. The company’s proprietary discovery engine Retrocyte DisplayTM is used to generate fully human and humanized therapeutic antibody drug candidates. The Retrocyte Display platform uses a high-throughput approach incorporating IgG format human antibody libraries expressed in mammalian B-lineage cells. Agenus recently acquired ...
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

I D Medical Systems Inc

I D Medical Systems Inc is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avery Manor

Avery Manor is a Needham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BridgePoint Medical

BridgePoint Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Veran Medical Technologies

Veran Medical Technologies, Inc., an image guided medical device company, develops a suite of products to enable physicians to diagnose disease and deliver therapies. It offers standards for minimally invasive delivery of interventional oncology therapies. The company provides plug-n-play delivery systems and navigated instruments. Its IG4 Platform allows clinicians to visualize various types of information integrated with a CT dataset, such as respiration, contrast enhanced structures, PET, and ultrasound. The company also provides SPiN Drive System that acts as a GPS-like system to enable pulmonologists and surgeons to access peripheral solitary pulmonary nodules to diagnose malignancy. Veran Medical Technologies, Inc. was incorporated in 2007 and is headquartered in St. Louis, Missouri.

NexCore Group

NexCore Group delivers comprehensive healthcare real estate solutions for hospitals, healthcare systems, and physician partners across the United States. NexCore and its principals have developed and acquired over 3.8 million square feet of outpatient care centers, including 450,000 square feet currently in planning and development. In addition, NexCore’s in-house leasing team has executed over 3.5 million square feet of medical office leases in over 20 states. At NexCore, we leverage our competitive capital, healthcare business intelligence, location intelligence, and flexible development approach to deliver outpatient facilities that provide a competitive edge in the marketplace and anticipate the demands of healthcare reform. NexCore consistently produces tangible results for our clients that include lower lease rates and operating costs, increased market share, physician alignment, improved efficiency for providers, increased patient satisfaction, and sustainability. We are actively engaged in the development of medical office buildings, health villages, medical fitness centers, wellness centers, cancer centers, orthopedic centers, urgent care centers, freestanding emergency departments, and multispecialty physician group facilities. Our team has provided planning, development, finance, and leasing services for prominent health systems across the country such as Ascension Health, Catholic Health Initiatives, CHE/Trinity Health, Providence Health & Services, UNC Health Care, and HealthONE. NexCore has grown into a 50-person property development company recognized repeatedly as one of the Top Healthcare Real Estate Developers in the U.S. by Modern Healthcare magazine. The company is also proud to be a Best Practice Partner of the Medical Fitness Association.